Solasia Pharma KK
TSE:4597
Solasia Pharma KK
TSE:4597
Price:
28 JPY
3.7%
Market Closed
Updated:
May 14, 2024
Solasia Pharma KK
Cash from Operating Activities
|
Solasia Pharma KK
Cash from Operating Activities Peer Comparison
Comparables:
2160
4587
4974
J
7774
S
4599
Competitive Cash from Operating Activities Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Cash from Operating Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Solasia Pharma KK
TSE:4597
|
Cash from Operating Activities
-¥359m
|
CAGR 3-Years
50%
|
CAGR 5-Years
31%
|
CAGR 10-Years
N/A
|
|
|
GNI Group Ltd
TSE:2160
|
Cash from Operating Activities
¥6.5B
|
CAGR 3-Years
68%
|
CAGR 5-Years
61%
|
CAGR 10-Years
N/A
|
|
|
PeptiDream Inc
TSE:4587
|
Cash from Operating Activities
¥12.4B
|
CAGR 3-Years
93%
|
CAGR 5-Years
25%
|
CAGR 10-Years
N/A
|
|
|
Takara Bio Inc
TSE:4974
|
Cash from Operating Activities
¥24.1B
|
CAGR 3-Years
36%
|
CAGR 5-Years
26%
|
CAGR 10-Years
27%
|
|
J
|
Japan Tissue Engineering Co Ltd
TSE:7774
|
Cash from Operating Activities
-¥138.5m
|
CAGR 3-Years
16%
|
CAGR 5-Years
6%
|
CAGR 10-Years
17%
|
|
S
|
StemRIM Inc
TSE:4599
|
Cash from Operating Activities
¥1.1B
|
CAGR 3-Years
25%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Solasia Pharma KK's Cash from Operating Activities?
Cash from Operating Activities
-359m
JPY
-359m
JPY
Based on the financial report for Dec 31, 2023, Solasia Pharma KK's Cash from Operating Activities amounts to -359m JPY.
What is Solasia Pharma KK's Cash from Operating Activities growth rate?
Cash from Operating Activities CAGR 5Y
31%
31%
Over the last year, the Cash from Operating Activities growth was 83%. The average annual Cash from Operating Activities growth rates for Solasia Pharma KK have been 50% over the past three years , 31% over the past five years .
You don't have any saved screeners yet
